Trademarkia Logo

Canada

C$
EPI-R
ADVERTISED

on 4 Dec 2024

Last Applicant/ Owned by

Lyell Immunopharma, Inc.

201 Haskins WaySouth San Francisco, CA 94080

US

Serial Number

2188416 filed on 27th May 2022

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

EPI-R

Trademark usage description

scientific and technological services and biological research and development relating thereto, namely, research and development utilizing integrated Read More

Classification Information


Class [042]
Scientific and technological services and biological research and development relating thereto, namely, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; scientific and technological services and biological research and development, namely, research and development related to treatment of cancer


Classification kind code

11

Class [044]
Medical services, namely, medical services utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; medical services for treatment of cancer


Classification kind code

11

Mark Details


Serial Number

2188416

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 4th Dec 2024
Advertised
Submitted for opposition 26
on 11th Nov 2024
Approved
Submitted for opposition 27
on 11th Nov 2024
Approval Notice Sent
Submitted for opposition 22
on 1st Nov 2024
Search Recorded
Submitted for opposition 287
on 20th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 27th May 2022
Filed
Submitted for opposition 1
on 27th May 2022
Created
Submitted for opposition 31
on 27th May 2022
Formalized